Supernus Pharmaceuticals (SUPN) Bucks Market Downtrend on Royalty Agreement, Activist Investor
Tweet Send to a Friend
Supernus Pharmaceuticals (NASDAQ: SUPN) is bucking the market downdraft Tuesday (+1%) amid a few items:Supernus Pharmaceuticals announced the execution of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
